Hinge Health, Inc. HNGE

Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.

• Zacks Investment Research 21 sept

  Reasons to Hold Hinge Health Stock in Your Portfolio for Now

  Hinge Health (HNGE) raised its 2026 revenue guidance to $856-$860M following a 53% Q2 revenue jump to $212.8M. The company is expanding beyond its core MSK platform into Migraine Care (450 clients, 5M lives) and acquiring Cylinder Health for $105M to accelerate GI expansion. While growth prospects remain strong with a 30.6% expected growth rate, continued product investments and integration costs could temper margin expansion.

  

• The Motley Fool 12 jul

  A Hinge Health Backer Sold $38.4 Million in Stock After a 101% Run

  Insight Holdings Group, an early backer of Hinge Health, sold 426,000 shares worth $38.4 million at $90.21 per share following the stock's 101% one-year appreciation. The sale was executed through a routine options exercise and immediate liquidation, not a complete exit, as the firm retains substantial derivative securities. Hinge Health continues to show strong fundamentals with Q1 revenue growth of 47% and expanding margins driven by AI automation.

  

• GlobeNewswire Inc. 24 jun

  Digital Health for the Musculoskeletal Care Market: 2026-2032 Outlook | Increasing Investment in Health and Fitness Apps Drives Adoption of Digital Health Solutions for Musculoskeletal Health Tracking

  The global digital health for musculoskeletal care market is projected to grow from $3.8 billion in 2025 to $10.9 billion by 2032, with a CAGR of 16.4%. Growth is driven by rising MSK disorder prevalence, wearable device adoption, AI-powered remote physiotherapy, telehealth expansion, and increasing insurance coverage for digital MSK solutions.

  

• The Motley Fool 12 jun

  Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares?

  Hinge Health's co-founder Gabriel Mecklenburg sold 50,000 Class A shares worth $3.28 million on June 5, 2026. However, the article suggests this is not a major red flag as Mecklenburg retains 2.97 million shares in Class B holdings. The company shows strong fundamentals with 47% year-over-year sales growth, expanding margins (85% gross margin), and robust free cash flow generation ($41.6 million in Q1).